Haematologica

A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo.

Arruda LCM, Stikvoort A, Lambert M, ..., Carlsten M, Uhlin M

Haematologica 107 (8) 1786-1795 [2022-08-01; online 2022-08-01]

Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.

Martín-Izquierdo M, Abáigar M, Hernández-Sánchez JM, ..., Díez-Campelo M, Hernández-Rivas JM

Haematologica 106 (8) 2215-2223 [2021-08-01; online 2021-08-01]

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome.

Baliakas P, Forsberg LA

Haematologica 106 (2) 329-331 [2021-02-01; online 2021-02-01]

Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.

Leeksma AC, Baliakas P, Moysiadis T, ..., Mellink C, Kater AP

Haematologica 106 (1) 87-97 [2021-01-01; online 2021-01-01]

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types.

Majumder MM, Leppä AM, Hellesøy M, ..., Gjertsen BT, Heckman CA

Haematologica 105 (6) 1527-1538 [2020-06-00; online 2019-08-22]

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Depreter B, Weening KE, Vandepoele K, ..., Lammens T, Philippé J

Haematologica 105 (5) 1306-1316 [2020-05-00; online 2019-08-01]

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.

Leivonen SK, Pollari M, Brück O, ..., Mustjoki S, Leppä S

Haematologica 104 (2) 338-346 [2019-02-00; online 2018-09-20]

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Baliakas P, Moysiadis T, Hadzidimitriou A, ..., Stamatopoulos K, European Research Initiative on CLL (ERIC)

Haematologica 104 (2) 360-369 [2019-02-00; online 2018-09-27]

PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma.

Pollari M, Brück O, Pellinen T, ..., Leivonen SK, Leppä S

Haematologica 103 (11) 1908-1914 [2018-11-00; online 2018-07-19]

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.

Agathangelidis A, Ljungström V, Scarfò L, ..., Rosenquist R, Ghia P

Haematologica 103 (5) 865-873 [2018-05-00; online 2018-02-15]

Affiliated researcher

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Baliakas P, Mattsson M, Hadzidimitriou A, ..., Rosenquist R, Stamatopoulos K

Haematologica 103 (4) e158-e161 [2018-04-00; online 2017-12-21]

Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification.

Sutton LA, Hadzidimitriou A, Baliakas P, ..., Stamatopoulos K, European Research Initiative on CLL (ERIC)

Haematologica 102 (6) 968-971 [2017-06-00; online 2017-06-02]

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.

Palma M, Gentilcore G, Heimersson K, ..., Österborg A, Mellstedt H

Haematologica 102 (3) 562-572 [2017-03-00; online 2016-12-07]

Affiliated researcher

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Rosenquist R, Rosenwald A, Du MQ, ..., Stamatopoulos K, European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP)

Haematologica 101 (9) 1002-1009 [2016-09-00; online 2016-09-02]

Affiliated researcher

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.

Sutton LA, Young E, Baliakas P, ..., Rosenquist R, ERIC, the European Research Initiative on CLL

Haematologica 101 (8) 959-967 [2016-08-00; online 2016-05-19]

Affiliated researcher

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Baliakas P, Puiggros A, Xochelli A, ..., Espinet B, Stamatopoulos K

Haematologica 101 (7) e299-e302 [2016-07-00; online 2016-04-21]

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi S, Baliakas P, Cortese D, ..., Sutton LA, Mansouri L

Haematologica 101 (2) e63-e65 [2016-02-00; online 2015-11-20]

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Nakasone H, Remberger M, Tian L, ..., Miklos DB, Meyer E

Haematologica 100 (11) 1477-1485 [2015-11-00; online 2015-08-06]

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.

Karimi M, Nilsson C, Dimitriou M, ..., Kere J, Hellström-Lindberg E

Haematologica 100 (6) e223-e225 [2015-06-00; online 2015-03-13]

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Sutton LA, Ljungström V, Mansouri L, ..., Stamatopoulos K, Rosenquist R

Haematologica 100 (3) 370-376 [2015-03-00; online 2014-12-05]

Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Sutton LA, Rosenquist R

Haematologica 100 (1) 7-16 [2015-01-00; online 2015-01-02]

Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.

Bergh AC, Evaldsson C, Pedersen LB, ..., Rosenquist R, Rosén A

Haematologica 99 (11) 1722-1730 [2014-11-00; online 2014-08-01]

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.

Benner A, Mansouri L, Rossi D, ..., Zenz T, European Research Initiative on CLL (ERIC)

Haematologica 99 (8) 1285-1291 [2014-08-00; online 2014-08-02]

Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.

Kremer AN, van der Griendt JC, van der Meijden ED, ..., Falkenburg JH, Griffioen M

Haematologica 99 (2) 365-369 [2014-02-00; online 2013-10-04]